Global Synthetic Biology Market Size, Share, and COVID-19 Impact Analysis, By Product (Enzymes, Chassis Organisms, Oligonucleotides & Synthetic DNA, Cloning & Sequencing, Xeno-Nucleic Acids & Others), By Technology (Genome Engineering, Bioinformatics, Microfluidics, Sequencing, Measurement and Modeling, Nanotechnology & Others), By Application (Pharmaceuticals & Diagnostics, Chemicals, Food & Agriculture, Biofuels, and Others), By End-User (Biotechnology & Pharmaceutical Industry, Academics & Research Institutes, and Others) and by Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) Analysis and Forecast 2022-2030

KEY MARKET INSIGHTS

The global synthetic biology market was valued at USD 9.6 Bn in 2021. The market is projected to grow USD 30.8 Bn in 2030, at a CAGR of 23%. Synthetic biology refers to the process of redesigning existing organisms to serve new functions. It involves an interdisciplinary field of study that aims to develop novel biological components, machinery, and systems or to remodel existing natural systems. Synthetic biology is being used by researchers to create new tools, services, and products that offer substantial and genuine benefits. The goal of the developing, interdisciplinary discipline of synthetic biology is to simplify and improve the design, development, and optimization of biological systems.

COVID-19 ANALYSIS

The COVID-19 presented a number of difficulties for cancer treatments, particularly in ensuring treatment continuation during the pandemic. Within a short period of time, it had a huge impact on economies and healthcare systems. Recent years have seen an increase in the importance of systems biology approaches for encouraging the creation of novel medicinal medications, however the market for synthetic biology has been severely impacted by the COVID-19 outbreak danger.

LATEST TREND

Customized Synthetic Biology is Gaining Lot of Attention

The concept of customized synthetic biology is growing more popular in developed markets, and it is likely to grow in popularity in developing areas in the coming years. The goal of the developing, interdisciplinary discipline of synthetic biology is to simplify and improve the design, development, and optimization of biological systems. The functioning of biological systems is necessary for advances in synthetic biology. In addition, despite biology's lack of predictability, a rise in the creation of tiny molecules utilizing synthetic biology techniques boosts the market.

DRIVERS

Growing Applications of Synthetic Biology

The growing applications of synthetic biology is fueling the growth of the global synthetic biology market. Wide range of applications, which is anticipated to boost market expansion. A wide range of industries, including bioenergy, enzyme technology, biology-based chemicals, antibody manufacture, and vaccine manufacturing, utilize products made using synthetic biology processes. Synthetic biology is being used by a number of businesses to produce materials and fabrics. Companies like Spiber, MycoWorks, Modern Meadow, and Bolt Threads are developing bio-based dyes as well as energy- and water-efficient textile production systems.

Rising Population Creates the Demand of Changing Food Habits

The rising population is creating the change in food consumption which is contributing to the research and development of the synthetic biology. The market for synthetic biology products rises as societal perceptions of synthetic biology change. With the aid of synthetic biology, a number of effective food production techniques have been discovered. The improvement of pest control management and the generation of improved food yields are anticipated benefits of the technique.

RESTRAINTS

Concerns Pertaining to Biosafety Associated with Synthetic Biology

The accidental or malicious release of synthetic organisms into the environment for research and other reasons is the main biosafety problem in synthetic biology. When artificial microorganisms are released into the environment, they have the potential to mutate or interact with other organisms, which could lead to cross-breeding with real creatures and the development of bio mistakes. The ecosystem of living things may be in danger as a result of these effects. A significant biosafety problem is the development of superbugs resistant to antibiotics.

SEGMENTATION INSIGHTS

The global synthetic biology market is segmented By Product (Enzymes, Chassis Organisms, Oligonucleotides & Synthetic DNA, Cloning & Sequencing, Xeno-Nucleic Acids & Others), by Technology (Genome Engineering, Bioinformatics, Microfluidics, Sequencing, Measurement and Modeling, Nanotechnology & Others), by Application (Pharmaceuticals & Diagnostics, Chemicals, Food & Agriculture, Biofuels, and Others), by End-User (Biotechnology & Pharmaceutical Industry, Academics & Research Institutes, and Others) and Region. Based on the product, the market is categorized into enzymes, chassis organisms, oligonucleotides & synthetic dna, cloning & sequencing, xeno-nucleic acids & others. Based on technology, the market is categorized into genome engineering, bioinformatics, microfluidics, sequencing, measurement and modeling, nanotechnology & others. Based on application, the market is categorized into pharmaceuticals & diagnostics, chemicals, food & agriculture, biofuels, and others. Based on end-user, the market is categorized into biotechnology & pharmaceutical industry, academics & research institutes, and others. Based on the region, the market is categorized into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

Product Insights

Based on product, is categorized into enzymes, chassis organisms, oligonucleotides & synthetic dna, cloning & sequencing, xeno-nucleic acids & others. The oligonucleotides & synthetic DNA segment is expected to dominate the market share of global synthetic biology market owing to many potentials in domains like molecular and synthetic biology as a result of the capacity to produce unique DNA oligos for studies. In order to create efficient biocatalysts for biological sciences and biomedicine, enzyme engineering is crucial. This is expected to fuel market expansion.

Application Insights

Based on Application, the market is categorized into pharmaceuticals & diagnostics, chemicals, food & agriculture, biofuels, and others. The pharmaceuticals & diagnostics is expected to dominate the market share of global synthetic biology market owing to diagnostics offer a real-time, highly accurate, non-invasive method for identifying cancer cells, infectious diseases, and medicines. Researchers create unique biosensing systems that are dynamic and comprised of a sensor, processor, and reporter using rational engineering methods. To identify Non-Alcoholic Steatohepatitis (NASH) early symptoms, gauge the severity of the condition, and aid in the development of new medications, Glympse Bio has created an activity-based biosensor.

End-User Insights

Based on end-user, the market is categorized into biotechnology & pharmaceutical industry, academics & research institutes, and others. The biotechnology & pharmaceutical industry segment is expected to dominate the market share of global synthetic biology market owing to the creation of new medications that can treat chronic illnesses by biotechnology and pharmaceutical businesses. For instance, Merck developed Januvia (sitagliptin) for diabetic patients using synthetic biology techniques. To treat B-cell acute lymphoblastic leukaemia, Novartis created Kymriah (Tisagenlecleucel). For instance, Codexis uses synthetic biology to create an enzyme that is more effective at producing small-molecule medicines.

REGIONAL INSIGHTS

The global synthetic biology market is categorized into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America region is expected to dominate the market share of global synthetic biology market owing to government support, favourable legislation, and increasing funding for the creation of synthetic biological products. In the first half of 2020, startups in this industry raised more than $3 billion in funding, including Moderna Therapeutics, Sana Biotechnology, Poseida Therapeutics, Apeel Sciences, and Greenlight Biosciences. The U.S. places a lot of emphasis on research in the fields of proteomics, genomic structure prediction, and drug development, which has a positive impact on the synthetic biology market. However, Europe region is expected to witness highest growth rate during the forecast period of global synthetic biology market due to the establishment of local start-ups and participation by top businesses, particularly in the biofuel sector, are all ongoing supports from the European government and private groups. because the subject is advancing thanks to the presence of multiple centres for synthetic biology. For instance, the Max Planck Society and Ministry of Education and Research's MaxSynBio division is engaged in identifying crucial biological pathways for the development of minimum cells. Similar to this, Leaps by Bayer, a programme of the German-based Bayer AG firm, funds developments in a range of life sciences, including synthetic biology. It is believed that the existence of such institutions will stimulate market expansion in Germany.

INDUSTRY PLAYERS

· Thermo Fisher Scientific

· Merck KGaA

· Agilent Technologies, Inc.

· Novozymes A/S

· Amyris

· Precigen

· GenScript

· Twist Bioscience

· Codexis

· Synthego

· Creative Enzymes

· Eurofins Scientific

· TeselaGen

· Arzeda

· Integrated DNA Technologies

· New England Biolabs

· Royal DSM

· OriGene Technologies, Inc.

· Illumina

KEY INDUSTRY DEVELOPMENTS:

December 2021- Codexis has launched Codex® HiTemp Reverse Transcriptase for use in one-step quantitative reverse transcription PCR (RT-qPCR).

January 2021- Novozymes launched Frontia GlutenEx. It would help wheat processors increase their gluten protein recovery and, at the same time, cut down on energy consumption.

SEGMENTATION

By Product

• Enzymes
• Chassis Organisms
• Oligonucleotides & Synthetic DNA
• Cloning & Sequencing
• Xeno-Nucleic Acids
• Others

By Technology

• Genome Engineering
• Bioinformatics
• Microfluidics
• Sequencing
• Measurement and Modeling
• Nanotechnology
• Others

By Application

• Pharmaceuticals & Diagnostics
• Chemicals
• Food & Agriculture
• Biofuels
• Others

By End-User

• Biotechnology & Pharmaceutical Industry
• Academics & Research Institutes
• Others

By Region

• North America- U.S., Mexico, Canada
• Europe- UK, France, Germany, Italy, Spain, Rest of Europe
• Asia-Pacific- China, Japan, India, South Korea, Rest of Asia Pacific
• South America- Brazil, Argentina, Colombia, Rest of South America
• The Middle East and Africa- GCC, South Africa, Rest of Middle East & Africa